US Periodontal Disease Treatment Market

The Report "US Periodontal Disease Treatment Market by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs) - Forecast to 2031" is projected to grow from USD 0.68 billion in 2026 and to reach USD 0.94 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.

Browse 120 market data Tables and 150 Figures spread through 270 Pages and in-depth TOC on "US Periodontal Disease Treatment Market by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs) - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/us-periodontal-disease-treatment-market-201891912.htm

The US periodontal disease treatment market is strongly driven by the growing prevalence of oral health disorders, including periodontal disease, gingivitis, and other chronic dental conditions, which continue to affect a large portion of the population. Rising cases of edentulism, especially among elderly individuals and patients with long-standing periodontal issues, are increasing the demand for advanced periodontal therapies and supporting equipment. Moreover, the emergence of innovative dental treatment procedures, including laser-based therapies, minimally invasive surgical techniques, and digitally enabled periodontal solutions, is enhancing treatment effectiveness, reducing recovery time, and encouraging adoption among dental professionals. In addition, the expanding dental tourism market in emerging economies is intensifying global competition, encouraging US manufacturers to focus on technological innovation, product differentiation, and enhanced treatment efficiency to maintain their market position.

This report categorizes the US periodontal disease treatment market based on product, disease, treatment, and end user.

“Gingivitis captured majority of market share in 2025.”

Based on disease, the US periodontal disease treatment market is segmented into Gingivitis, acute periodontitis, aggressive periodontitis, and others. Gingivitis accounts for the largest market share, primarily due to its high prevalence. As a mild and widely occurring form of periodontal disease, gingivitis affects a large portion of the population, driven by poor oral hygiene, smoking, and underlying conditions like diabetes. Its widespread occurrence results in strong demand for preventive treatments, particularly routine dental scaling procedures.

“Equipment segment accounted for majority of share of US periodontal disease treatment market in 2025.”

Based on product, the US periodontal disease treatment market is segmented into equipment, consumables, and medication. The equipment segment holds the largest share of the US periodontal disease treatment market. This is primarily due to the growing demand for accurate and early diagnosis of dental conditions, supported by the increasing prevalence of oral health issues such as dental caries, periodontal diseases, and oral cancers. Advanced dental equipment enables clinicians to identify problems earlier, resulting in improved treatment outcomes and increased patient satisfaction. In addition, the expansion of hospitals, dental clinics, and specialized dental care centers has led to an increase in the adoption of modern dental equipment, as new facilities are increasingly equipped with advanced diagnostic and treatment technologies to enhance care quality and efficiency.

“Non-surgical treatment segment held largest share of US periodontal disease treatment market in 2025.”

Based on treatment, the US periodontal disease treatment market is segmented into non-surgical treatment, flap surgery, soft tissue graft, bone grafting, guided tissue regeneration, and other treatments. Among these, the non-surgical treatment segment accounted for the largest share of the periodontal disease treatment market. This dominance is driven by patient preference for less invasive options, faster recovery times, and lower costs. Non-surgical approaches, such as scaling and root planing (deep cleaning), antimicrobial therapies, and laser treatments, are typically used as first-line treatments, especially in the early stages of periodontal disease. These methods help control infection, remove plaque and tartar below the gum line, and support healing without the need for surgical intervention.

“Hospitals held largest share of US periodontal disease treatment market in 2025.”

Based on end user, the US periodontal disease treatment market is segmented into hospitals, private and DSO clinics, and academic and research institutes. Hospitals hold the largest share of the US periodontal disease treatment market. This leadership is driven by the growing number of dental hospitals and multispecialty healthcare facilities, which attract a large patient base seeking comprehensive and specialized dental care. These hospitals are well-equipped to manage high patient volumes and complex procedures, leading to steady demand for advanced dental treatment technologies.

Key Market Players:

Key players in this market are adopting several organic and inorganic growth strategies (such as product launches, agreements, collaborations, acquisitions, and expansions). Some prominent players in this market include Dentsply Sirona (US), Envista  (US), A-dec Inc. (US), J. MORITA CORP. (Japan), Institut Straumann AG (Switzerland), BIOLASE, Inc. (US), BEGO GmbH & Co. KG (Germany), Ultradent Products, Inc. (US), Yoshida Dental MFG. Co., Ltd. (Japan), Nakanishi Inc. (Japan), Geistlich Pharma AG (Switzerland), RTI Surgical (US), and Keystone Dental Group (US).

Don’t miss out on business opportunities in US Periodontal Disease Treatment Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/